Anna Eriksson

Title: Anna Eriksson: Innovator in Proximity Extension Assays

Introduction

Anna Eriksson is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of proximity extension assays. With a total of 2 patents, her work focuses on improving detection methods for analytes in various samples.

Latest Patents

Anna Eriksson's latest patents include innovative methods that enhance the specificity and efficiency of proximity probe-based detection assays. The first patent, titled "Hyperthermophilic polymerase enabled proximity extension assay," describes a method that utilizes a hyperthermophilic polymerase to reduce non-specific background signals. This method involves several steps, including the interaction of nucleic acid domains of proximity probes and the amplification of the extension product at elevated temperatures.

The second patent, "Exonuclease enabled proximity extension assays," introduces a component with 3' exonuclease activity to further improve the detection process. This method also includes steps for binding analytes and amplifying the resulting extension product, ensuring high specificity in detection.

Career Highlights

Anna Eriksson is currently associated with Olink Proteomics AB, where she continues to advance her research in proteomics and assay development. Her innovative approaches have positioned her as a key figure in the biotechnology sector.

Collaborations

Some of her notable coworkers include Simon Fredriksson and Martin Lundberg, who contribute to the collaborative efforts in her research endeavors.

Conclusion

Anna Eriksson's contributions to the field of biotechnology through her patents and work at Olink Proteomics AB highlight her role as an influential inventor. Her innovative methods in proximity extension assays are paving the way for advancements in analyte detection.